| 000 | 01295 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250518005445.0 | ||
| 264 | 0 | _c20190322 | |
| 008 | 201903s 0 0 eng d | ||
| 022 | _a1177-8881 | ||
| 024 | 7 |
_a10.2147/DDDT.S177746 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAbou-Taleb, Heba A | |
| 245 | 0 | 0 |
_aIntranasal niosomes of nefopam with improved bioavailability: preparation, optimization, and in-vivo evaluation. _h[electronic resource] |
| 260 |
_bDrug design, development and therapy _c2018 |
||
| 300 |
_a3501-3516 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Intranasal |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBiological Availability |
| 650 | 0 | 4 |
_aCholesterol _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Delivery Systems |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aLiposomes |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNefopam _xadministration & dosage |
| 650 | 0 | 4 | _aParticle Size |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aSurface-Active Agents _xadministration & dosage |
| 700 | 1 | _aKhallaf, Rasha A | |
| 700 | 1 | _aAbdel-Aleem, Jelan A | |
| 773 | 0 |
_tDrug design, development and therapy _gvol. 12 _gp. 3501-3516 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2147/DDDT.S177746 _zAvailable from publisher's website |
| 999 |
_c29026142 _d29026142 |
||